FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3154586727> ?p ?o ?g. }

• W3154586727 endingPage "e28973" @default.
• W3154586727 startingPage "e28973" @default.
• W3154586727 abstract "Background On January 30, 2020, the World Health Organization’s Emergency Committee declared the rapid, worldwide spread of COVID-19 a global health emergency. Since then, tireless efforts have been made to mitigate the spread of the disease and its impact, and these efforts have mostly relied on nonpharmaceutical interventions. By December 2020, the safety and efficacy of the first COVID-19 vaccines were demonstrated. The large social media platform Twitter has been used by medical researchers for the analysis of important public health topics, such as the public’s perception on antibiotic use and misuse and human papillomavirus vaccination. The analysis of Twitter-generated data can be further facilitated by using Twitter’s built-in, anonymous polling tool to gain insight into public health issues and obtain rapid feedback on an international scale. During the fast-paced course of the COVID-19 pandemic, the Twitter polling system has provided a viable method for gaining rapid, large-scale, international public health insights on highly relevant and timely SARS-CoV-2–related topics. Objective The purpose of this study was to understand the public’s perception on the safety and acceptance of COVID-19 vaccines in real time by using Twitter polls. Methods We developed 2 Twitter polls to explore the public’s views on available COVID-19 vaccines. The surveys were pinned to the Digital Health and Patient Safety Platform Twitter timeline for 1 week in mid-February 2021, and Twitter users and influencers were asked to participate in and retweet the polls to reach the largest possible audience. Results The adequacy of COVID-19 vaccine safety (ie, the safety of currently available vaccines; poll 1) was agreed upon by 1579 out of 3439 (45.9%) Twitter users. In contrast, almost as many Twitter users (1434/3439, 41.7%) were unsure about the safety of COVID-19 vaccines. Only 5.2% (179/3439) of Twitter users rated the available COVID-19 vaccines as generally unsafe. Poll 2, which addressed the question of whether users would undergo vaccination, was answered affirmatively by 82.8% (2862/3457) of Twitter users, and only 8% (277/3457) categorically rejected vaccination at the time of polling. Conclusions In contrast to the perceived high level of uncertainty about the safety of the available COVID-19 vaccines, we observed an elevated willingness to undergo vaccination among our study sample. Since people's perceptions and views are strongly influenced by social media, the snapshots provided by these media platforms represent a static image of a moving target. Thus, the results of this study need to be followed up by long-term surveys to maintain their validity. This is especially relevant due to the circumstances of the fast-paced pandemic and the need to not miss sudden rises in the incidence of vaccine hesitancy, which may have detrimental effects on the pandemic’s course." @default.
• W3154586727 created "2021-04-26" @default.
• W3154586727 creator A5006992111 @default.
• W3154586727 creator A5027960403 @default.
• W3154586727 creator A5036342595 @default.
• W3154586727 creator A5037016137 @default.
• W3154586727 creator A5051247800 @default.
• W3154586727 creator A5053327063 @default.
• W3154586727 creator A5056740547 @default.
• W3154586727 creator A5061155886 @default.
• W3154586727 creator A5065781341 @default.
• W3154586727 creator A5077638596 @default.
• W3154586727 creator A5082181563 @default.
• W3154586727 creator A5089774852 @default.
• W3154586727 creator A5090962202 @default.
• W3154586727 date "2021-04-29" @default.
• W3154586727 modified "2023-09-27" @default.
• W3154586727 title "People’s Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis" @default.
• W3154586727 cites W1485941188 @default.
• W3154586727 cites W2143216598 @default.
• W3154586727 cites W2553110962 @default.
• W3154586727 cites W2560678864 @default.
• W3154586727 cites W2930122242 @default.
• W3154586727 cites W2945303479 @default.
• W3154586727 cites W3006419170 @default.
• W3154586727 cites W3008193409 @default.
• W3154586727 cites W3009155494 @default.
• W3154586727 cites W3009765141 @default.
• W3154586727 cites W3010571899 @default.
• W3154586727 cites W3012455658 @default.
• W3154586727 cites W3015792206 @default.
• W3154586727 cites W3017190864 @default.
• W3154586727 cites W3024744598 @default.
• W3154586727 cites W3030381264 @default.
• W3154586727 cites W3032742287 @default.
• W3154586727 cites W3034495099 @default.
• W3154586727 cites W3048095007 @default.
• W3154586727 cites W3050078981 @default.
• W3154586727 cites W3084593143 @default.
• W3154586727 cites W3092748982 @default.
• W3154586727 cites W3093974194 @default.
• W3154586727 cites W3111255098 @default.
• W3154586727 cites W3111590711 @default.
• W3154586727 cites W3111809220 @default.
• W3154586727 cites W3116104974 @default.
• W3154586727 cites W3119345685 @default.
• W3154586727 cites W3127329393 @default.
• W3154586727 cites W3128038244 @default.
• W3154586727 cites W3128864568 @default.
• W3154586727 cites W3129515972 @default.
• W3154586727 cites W3131645232 @default.
• W3154586727 cites W3132689925 @default.
• W3154586727 cites W3165438920 @default.
• W3154586727 cites W4205483821 @default.
• W3154586727 doi "https://doi.org/10.2196/28973" @default.
• W3154586727 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8086789" @default.
• W3154586727 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33872185" @default.
• W3154586727 hasPublicationYear "2021" @default.
• W3154586727 type Work @default.
• W3154586727 sameAs 3154586727 @default.
• W3154586727 citedByCount "58" @default.
• W3154586727 countsByYear W31545867272021 @default.
• W3154586727 countsByYear W31545867272022 @default.
• W3154586727 countsByYear W31545867272023 @default.
• W3154586727 crossrefType "journal-article" @default.
• W3154586727 hasAuthorship W3154586727A5006992111 @default.
• W3154586727 hasAuthorship W3154586727A5027960403 @default.
• W3154586727 hasAuthorship W3154586727A5036342595 @default.
• W3154586727 hasAuthorship W3154586727A5037016137 @default.
• W3154586727 hasAuthorship W3154586727A5051247800 @default.
• W3154586727 hasAuthorship W3154586727A5053327063 @default.
• W3154586727 hasAuthorship W3154586727A5056740547 @default.
• W3154586727 hasAuthorship W3154586727A5061155886 @default.
• W3154586727 hasAuthorship W3154586727A5065781341 @default.
• W3154586727 hasAuthorship W3154586727A5077638596 @default.
• W3154586727 hasAuthorship W3154586727A5082181563 @default.
• W3154586727 hasAuthorship W3154586727A5089774852 @default.
• W3154586727 hasAuthorship W3154586727A5090962202 @default.
• W3154586727 hasBestOaLocation W31545867271 @default.
• W3154586727 hasConcept C108827166 @default.
• W3154586727 hasConcept C111919701 @default.
• W3154586727 hasConcept C134698397 @default.
• W3154586727 hasConcept C136764020 @default.
• W3154586727 hasConcept C138816342 @default.
• W3154586727 hasConcept C142724271 @default.
• W3154586727 hasConcept C159110408 @default.
• W3154586727 hasConcept C166957645 @default.
• W3154586727 hasConcept C17744445 @default.
• W3154586727 hasConcept C199539241 @default.
• W3154586727 hasConcept C204854418 @default.
• W3154586727 hasConcept C27415008 @default.
• W3154586727 hasConcept C2779134260 @default.
• W3154586727 hasConcept C3008058167 @default.
• W3154586727 hasConcept C39549134 @default.
• W3154586727 hasConcept C41008148 @default.
• W3154586727 hasConcept C4438859 @default.
• W3154586727 hasConcept C518677369 @default.
• W3154586727 hasConcept C524204448 @default.

• next